Etiology and clinical management of anemia in heart failure. GESAIC study;Etiología y tratamiento de la anemia en la insuficiencia cardíaca. Estudio GESAIC

Medicina Clinica

Volumn 132, Issue 12, 2009, Pages 447-453

  Grau Amorós, Jorge ^a   Formiga, Francesc ^b   Jordana Comajuncosa, Rosa ^c   Urrutia, Agustín ^d   Arias Jiménez, José L ^e   Salvador Mínguez, Juan P ^f  

^a Hospital Municipal de Badalona   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Consorci Hospitalari del Parc Taulí ^*  (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f Hospital de Alcañiz Alcañiz   (Spain)

Author keywords

Anemia; Etiology; Heart failure; Renal failure

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; IRON;

AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE;

AGED; ANEMIA; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 63349084185     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.10.055     Document Type: Article

References (28)

1. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
2. Szachniewicz J., Petruk-Kowalczyk J., Majda J., Kaczmarek A., Reczuch K., Kalra P.R., et al. Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 90 (2003) 303-308
3. Lupón J., Urrutia A., González B., Herreros J., Altimir S., Coll R., et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardíaca. Rev Esp Cardiol 58 (2005) 48-53
4. Domínguez Franco A., Peña Hernández J., Pérez Caravante M., Muñoz García A., Jiménez Navarro M., and De Teresa Galván E. Significado pronóstico a largo plazo de la anemia en una población no seleccionada de pacientes con insuficiencia cardiaca. Med Clin (Barc) 128 (2007) 370-371
5. Cromie N., Lee C., and Struthers A.D. Anemia in chronic heart failure: what is its frequency in the UK and its underlying causes?. Heart 87 (2002) 377-378
6. García de Casasola G., Cárdenas Franco C., Vegas Serrano A., Hornero Izquierdo M.A., Guijarro Herraiz C., and Zapatero Gaviria A. La anemia es un factor pronóstico de mortalidad en la insuficiencia cardiaca. An Med Interna (Madrid) 22 (2005) 271-274
7. Nanas J.N., Matsouka C., Karageorgopoulos D., Leonti A., Tsolakis E., Dragos S.G., et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48 (2006) 2485-2489
8. Androne A.S., Katz S.D., Lund L., LaManca J., Hudaihed A., Hryniewicz K., et al. Hemodilution is common in patients with advanced heart failure. Circulation 107 (2003) 226-229
9. Formiga F., Chivite D., Castañera O., Manito N., Ramón J.M., and Pujol R. Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation. Eur J Intern Med 17 (2006) 179-184
10. O'Meara E., Clayton T., McEntegart M.B., McMurray J.J.V., Lang C.C., Roger S.D., et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 113 (2006) 986-994
11. Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. J Card Fail 10 Suppl 1 (2004) S1-S4
12. Tang Y., and Katz S.D. Anemia in chronic heart failure prevalence, etiology, clinical correlates, and treatment options. Circulation 113 (2006) 2454-2461
13. Grau-Amorós J., Formiga F., Jordana-Comajuncosa R., Urrutia A., Aramburu Bodas O., and Ceresuela L.M. Prevalencia de la anemia en la insuficiencia cardíaca. Resultados del estudio GESAIC. Rev Clin Esp 208 (2008) 211-215
14. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 149 (2005) 391-401
15. Grupo de Trabajo de Diagnóstico y Tratamiento de la Insuficiencia Cardíaca Crónica de la Sociedad Europea de Cardiología. Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Rev Esp Cardiol 58 (2005) 1062-1092
16. Mckee P.A., Castelli W.P., Mcamara P.M., and Kannel W.B. The natural history for congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1439-1443
17. Mahoney F.I., and Barthel D.W. Functional evaluation: the Barthel index. Med State Med J 14 (1965) 61-65
18. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficits in the elderly. J Am Geriatr Soc 23 (1975) 433-441
19. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 378-383
20. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
21. WHO/UNICEF/UNU. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. [Acceso 10 Feb 2008.] Geneva, World Health Organization, 2001 (WHO/NHD/01.3). Disponible en: http://whqlibdoc.who.int/hq/2001/WHO_NHD_01.3.pdf.
22. Kosiborod M., Smith G.L., Radford M.J., Foody J.M., and Krumholz H.M. The prognostic importance of anemia in patients with heart failure. Am J Med 114 (2003) 112-119
23. Berry C., Norrie J., Hogg K., Brett M., Stevenson K., and McMurray J.J.V. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J 151 (2006) 1313-1321
24. Terrovitis J.V., Anastasiou-Nana M.I., Alexopoulos G.P., Tsolakis E.J., Margari Z.J., Drakos S.G., et al. Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant 25 (2006) 333-338
25. Silverberg D.S., Wexler D., and Laina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 4 (2002) 681-686
26. Sica D.A. Pharmacotherapy in congestive heart failure. ACE inhibitors and anemia in congestive heart failure. Congest Heart Fail 6 (2000) 330-332
27. Felker G.M., Gattis W.A., Leimberger J.D., Adams K.F., Cuffe M.S., Gheorghiade M., et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 92 (2003) 625-628
28. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299